TransCode Therapeutics, Inc. - Common Stock
TransCode Therapeutics, Inc. - Common Stock
Acción · US89357L3033 · RNAZ (XNAS)
Resumen Indicadores financieros
6,91 USD
-4,43 % -0,32 USD
NASDAQ (XNAS) · Precios actuales y gráficos en MoneyPeak
13.06.2025 19:55

Cotizaciones actuales de TransCode Therapeutics, Inc. - Common Stock

BolsaTickerMonedaÚltima operaciónPrecioVariación diaria
XNAS: NASDAQ
NASDAQ
RNAZ
USD
13.06.2025 19:55
6,91 USD
7,21 USD
-4,09 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % -2,68 % -29,31 % -67,14 % -96,67 % -99,37 % -100,00 %

Firmenprofil zu TransCode Therapeutics, Inc. - Common Stock Aktie

TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. The company's products in preclinical programs include TTX-siPDL1, an siRNA-based modulator of programmed death-ligand 1; TTX-siLIN28B, an siRNA-based inhibitor of RNA-binding protein LIN28B. Its cancer agnostic programs comprise TTX-RIGA, an RNA–based agonist of the RIG-I-driven immune response in the tumor microenvironment; TTX-CRISPR, a CRISPR/Cas9–based therapy platform for the repair or elimination of cancer-causing genes inside tumor cells; and TTX-mRNA, an mRNA-based platform for the development of cancer vaccines meant to activate cytotoxic immune responses against tumor cells. The company was incorporated in 2016 and is based in Boston, Massachusetts.

Unternehmensdaten

Name TransCode Therapeutics, Inc. - Common Stock
Firma TransCode Therapeutics, Inc.
Symbol RNAZ
Website https://www.transcodetherapeutics.com
Heimatbörse XNAS NASDAQ
ISIN US89357L3033
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. Thomas A. Fitzgerald M.B.A.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,0 T
Adresse 6 Liberty Square, 02109 Boston
IPO Datum 2021-07-08

Aktien-Splits

Datum Split
15.05.2025 1:28
04.12.2024 1:33

Ticker Symbole

Name Symbol
NASDAQ RNAZ

Weitere Aktien

Investoren die TransCode Therapeutics, Inc. - Common Stock die halten, haben auch folgende Aktien im Depot:
CNH INDUSTR. 15/25
CNH INDUSTR. 15/25 Anleihe
DT.PFBR.BANK MTN18/UNBEF.
DT.PFBR.BANK MTN18/UNBEF. Anleihe
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025